TY - JOUR T1 - Neuroprotective effects of curcumin. AU - Cole,Greg M, AU - Teter,Bruce, AU - Frautschy,Sally A, PY - 2007/6/16/pubmed PY - 2007/7/4/medline PY - 2007/6/16/entrez SP - 197 EP - 212 JF - Advances in experimental medicine and biology JO - Adv Exp Med Biol VL - 595 N2 - Neurodegenerative diseases result in the loss of functional neurons and synapses. Although future stem cell therapies offer some hope, current treatments for most of these diseases are less than adequate and ourbest hope is to prevent these devastating diseases. Neuroprotective approaches work best prior to the initiation of damage, suggesting that some safe and effective prophylaxis would be highly desirable. Curcumin has an outstanding safety profile and a number of pleiotropic actions with potential for neuroprotective efficacy, including anti-inflammatory, antioxidant, and anti-protein-aggregate activities. These can be achieved at submicromolar levels. Curcumin's dose-response curves are strongly dose dependent and often biphasic so that in vitro data need to be cautiously interpreted; many effects might not be achievable in target tissues in vivo with oral dosing. However, despite concerns about poor oral bioavailability, curcumin has at least 10 known neuroprotective actions and many of these might be realized in vivo. Indeed, accumulating cell culture and animal model data show that dietary curcumin is a strong candidate for use in the prevention or treatment of major disabling age-related neurodegenerative diseases like Alzheimer's, Parkinson's, and stroke. Promising results have already led to ongoing pilot clinical trials. SN - 0065-2598 UR - https://www.unboundmedicine.com/medline/citation/17569212/Neuroprotective_effects_of_curcumin_ L2 - https://dx.doi.org/10.1007/978-0-387-46401-5_8 DB - PRIME DP - Unbound Medicine ER -